121 related articles for article (PubMed ID: 26895084)
1. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
Antonsson A; Knight L; Whiteman DC;
Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
[TBL] [Abstract][Full Text] [Related]
2. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
[TBL] [Abstract][Full Text] [Related]
3. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
4. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
[TBL] [Abstract][Full Text] [Related]
5. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance.
Iyer A; Rajendran V; Adamson CS; Peng Z; Cooper K; Evans MF
J Clin Virol; 2011 Mar; 50(3):205-8. PubMed ID: 21169053
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus.
Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review.
Kunzmann AT; Graham S; McShane CM; Doyle J; Tommasino M; Johnston B; Jamison J; James JA; McManus D; Anderson LA
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):817-825. PubMed ID: 28252462
[TBL] [Abstract][Full Text] [Related]
10. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.
Ferrer-Torres D; Nancarrow DJ; Kuick R; Thomas DG; Nadal E; Lin J; Chang AC; Reddy RM; Orringer MB; Taylor JM; Wang TD; Beer DG
Oncotarget; 2016 Aug; 7(34):54867-54882. PubMed ID: 27363029
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review.
Rajendra S; Pavey D; McKay O; Merrett N; Gautam SD
Ann N Y Acad Sci; 2020 Dec; 1482(1):36-48. PubMed ID: 33103249
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event.
Rai N; Jenkins GJ; McAdam E; Hibbitts SJ; Fiander AN; Powell NG
J Clin Virol; 2008 Oct; 43(2):250-2. PubMed ID: 18718811
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma.
Rajendra S; Xuan W; Hufnagel K; Sharma P; Pavey D; Alhajjiri N; Rattan A; Wang B
Ann N Y Acad Sci; 2020 Jun; 1470(1):44-56. PubMed ID: 32170783
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China.
Chang F; Syrjänen S; Shen Q; Cintorino M; Santopietro R; Tosi P; Syrjänen K
Anticancer Res; 2000; 20(5C):3935-40. PubMed ID: 11268480
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus and the risk of Barrett's esophagus.
El-Serag HB; Hollier JM; Gravitt P; Alsarraj A; Younes M
Dis Esophagus; 2013 Jul; 26(5):517-21. PubMed ID: 22891654
[TBL] [Abstract][Full Text] [Related]
16. Viral load and integration status of high-risk human papillomaviruses in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Wang B; Rajendra S; Pavey D; Sharma P; Merrett N; Wu X; Snow ET; Kumbhari V; Ball MJ; Robertson IK
Am J Gastroenterol; 2013 Nov; 108(11):1814-6. PubMed ID: 24192963
[No Abstract] [Full Text] [Related]
17. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
18. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract][Full Text] [Related]
19. Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature.
Türkay DÖ; Vural Ç; Sayan M; Gürbüz Y
Pathol Res Pract; 2016 Feb; 212(2):77-82. PubMed ID: 26608416
[TBL] [Abstract][Full Text] [Related]
20. Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: is HPV the common denominator?
Rajendra S; Robertson IK
J Clin Pathol; 2010 Jan; 63(1):1-3. PubMed ID: 20026700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
